AKT1 and COVID-19: The rise in IL-6 that accompanies COVID-19 may prevent autophosphorylation and activate the phosphoinositide 3 kinase (PI3K) [130] and protein kinase B (AKT) pathways, thereby worsening insulin resistance in diabetics [131,132].